153 related articles for article (PubMed ID: 17487394)
1. STAT3-decoy oligodeoxynucleotide inhibits the growth of human lung cancer via down-regulating its target genes.
Zhang X; Zhang J; Wei H; Tian Z
Oncol Rep; 2007 Jun; 17(6):1377-82. PubMed ID: 17487394
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice.
Zhang X; Zhang J; Wang L; Wei H; Tian Z
BMC Cancer; 2007 Aug; 7():149. PubMed ID: 17683579
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides.
Weerasinghe P; Garcia GE; Zhu Q; Yuan P; Feng L; Mao L; Jing N
Int J Oncol; 2007 Jul; 31(1):129-36. PubMed ID: 17549413
[TBL] [Abstract][Full Text] [Related]
4. Growth inhibition of human hepatocellular carcinoma cells by blocking STAT3 activation with decoy-ODN.
Sun X; Zhang J; Wang L; Tian Z
Cancer Lett; 2008 Apr; 262(2):201-13. PubMed ID: 18248786
[TBL] [Abstract][Full Text] [Related]
5. In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy.
Xi S; Gooding WE; Grandis JR
Oncogene; 2005 Feb; 24(6):970-9. PubMed ID: 15592503
[TBL] [Abstract][Full Text] [Related]
6. Efficient killing of SW480 colon carcinoma cells by a signal transducer and activator of transcription (STAT) 3 hairpin decoy oligodeoxynucleotide--interference with interferon-gamma-STAT1-mediated killing.
Tadlaoui Hbibi A; Laguillier C; Souissi I; Lesage D; Le Coquil S; Cao A; Metelev V; Baran-Marszak F; Fagard R
FEBS J; 2009 May; 276(9):2505-15. PubMed ID: 19476491
[TBL] [Abstract][Full Text] [Related]
7. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
Hellsten R; Johansson M; Dahlman A; Dizeyi N; Sterner O; Bjartell A
Prostate; 2008 Feb; 68(3):269-80. PubMed ID: 18163422
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo.
Gao L; Zhang L; Hu J; Li F; Shao Y; Zhao D; Kalvakolanu DV; Kopecko DJ; Zhao X; Xu DQ
Clin Cancer Res; 2005 Sep; 11(17):6333-41. PubMed ID: 16144938
[TBL] [Abstract][Full Text] [Related]
9. Stat3 activation is required for cell proliferation and tumorigenesis but not for cell viability in cutaneous squamous cell carcinoma cell lines.
Sumita N; Bito T; Nakajima K; Nishigori C
Exp Dermatol; 2006 Apr; 15(4):291-9. PubMed ID: 16512876
[TBL] [Abstract][Full Text] [Related]
10. [Targeted blockage of STAT5 by a decoy oligodeoxynucleotide inhibits the growth and proliferation of K562 cells].
Wang XZ; Feng WL; Shi M; Zeng JM; Tu ZG; Huang ZG
Zhonghua Xue Ye Xue Za Zhi; 2004 Dec; 25(12):724-7. PubMed ID: 15730714
[TBL] [Abstract][Full Text] [Related]
11. Tanshinone IIA inhibits constitutive STAT3 activation, suppresses proliferation, and induces apoptosis in rat C6 glioma cells.
Tang C; Xue HL; Huang HB; Wang XG
Neurosci Lett; 2010 Feb; 470(2):126-9. PubMed ID: 20045721
[TBL] [Abstract][Full Text] [Related]
12. Effects of a JAK inhibitor, AG490, on proliferation and apoptosis of human nasopharyngeal carcinoma cell line CNE-2Z.
Wu MH; Chen XY; Cai KR
Ai Zheng; 2009 Jan; 28(1):24-8. PubMed ID: 19448411
[TBL] [Abstract][Full Text] [Related]
13. STAT3 mRNA and protein expression in colorectal cancer: effects on STAT3-inducible targets linked to cell survival and proliferation.
Lassmann S; Schuster I; Walch A; Göbel H; Jütting U; Makowiec F; Hopt U; Werner M
J Clin Pathol; 2007 Feb; 60(2):173-9. PubMed ID: 17264243
[TBL] [Abstract][Full Text] [Related]
14. [Effects of STAT3 antisense oligonucleotide on proliferation and apoptosis of non-small cell lung cancer cell line A549].
Zhu BR; Cai JM; Tang GS; Li BL; Gao F; Cui JG; Liu HC
Ai Zheng; 2007 Aug; 26(8):820-7. PubMed ID: 17697540
[TBL] [Abstract][Full Text] [Related]
15. Expression of phosphorylated Stat3, cyclin D1 and Bcl-xL in extramammary Paget disease.
Liu HJ; Moroi Y; Masuda T; Yasumoto S; Kokuba H; Imafuku S; Koga T; Tetsuya T; Tu YT; Aburatani H; Furue M; Urabe K
Br J Dermatol; 2006 May; 154(5):926-32. PubMed ID: 16634897
[TBL] [Abstract][Full Text] [Related]
16. Role of STAT3 decoy oligodeoxynucleotides on cell invasion and chemosensitivity in human epithelial ovarian cancer cells.
Zhang X; Liu P; Zhang B; Wang A; Yang M
Cancer Genet Cytogenet; 2010 Feb; 197(1):46-53. PubMed ID: 20113836
[TBL] [Abstract][Full Text] [Related]
17. [Relationship of Stat3 and its target gene products with malignancy in human colorectal carcinoma].
Ma XT; Wang S; Ye YJ; Du RY; Cui ZR
Ai Zheng; 2003 Nov; 22(11):1135-9. PubMed ID: 14613639
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of decoy-ODN targeting activated STAT3 on human glioma growth in vivo.
Shen J; Li R; Li G
In Vivo; 2009; 23(2):237-43. PubMed ID: 19414409
[TBL] [Abstract][Full Text] [Related]
19. STAT3 blockade with shRNA enhances radiosensitivity in Hep-2 human laryngeal squamous carcinoma cells.
Li X; Wang H; Lu X; Di B
Oncol Rep; 2010 Feb; 23(2):345-53. PubMed ID: 20043094
[TBL] [Abstract][Full Text] [Related]
20. STAT3-decoy ODN inhibits cytokine autocrine of murine tumor cells.
Liu X; Li J; Zhang J
Cell Mol Immunol; 2007 Aug; 4(4):309-13. PubMed ID: 17764622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
